New HIV vaccine with a 97% antibody response rate in phase I human trials
New HIV vaccine with a 97% antibody response rate in phase I human trials
Apr 4, 2021, 8:26pm UTC
https://www.europeanpharmaceuticalreview.com/news/141892/novel-hiv-vaccine-approach-shows-promise-in-landmark-first-in-human-trial/